Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisRecruiting
NCT07477639Phase 1, Phase 2Updated Mar 19, 2026
Sponsor: Tr1X, Inc.
Primary Progressive Multiple Sclerosis · Secondary Progressive Multiple Sclerosis (SPMS) · Multiple Sclerosis · Multiple Sclerosis (MS) Primary Progressive
United States
MS Relapses During COVID-19 PandemicCompleted
NCT04858763N/AUpdated Mar 19, 2026
Sponsor: Nottingham University Hospitals NHS Trust
Multiple Sclerosis · Covid19 · Relapsing Remitting Multiple Sclerosis
United Kingdom
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor ImpairmentRecruiting
NCT06782464NAUpdated Mar 19, 2026
Sponsor: Centre National de Rééducation Fonctionnelle et de Réadaptation
Hemiplegia · Spasticity · Shoulder Spasticity · Shoulder Stiffness
Luxembourg
A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)Not Yet Recruiting
NCT07483632Phase 3Updated Mar 19, 2026
Sponsor: Biogen
Relapsing Forms of Multiple Sclerosis
A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS PatientsNot Yet Recruiting
NCT06513546Phase 1, Phase 2Updated Mar 19, 2026
Sponsor: PLL TX AUSTRALIA PTY LTD
Amyotrophic Lateral Sclerosis · ALS
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple SclerosisRecruiting
NCT04873492NAUpdated Mar 19, 2026
Sponsor: Nantes University Hospital
Multiple Sclerosis
France
Motor Asymmetry in Progressive Multiple Sclerosis PatientsCompleted
NCT04918225N/AUpdated Mar 19, 2026
Sponsor: Rennes University Hospital
Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Secondary Progressive
France
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple SclerosisRecruiting
NCT06599307Phase 2Updated Mar 18, 2026
Sponsor: Cairo University
Secondary Progressive Multiple Sclerosis (SPMS)
Egypt
Remote Assessment and Intervention for Behavior Problems in Kids With TSCCompleted
NCT06311474NAUpdated Mar 18, 2026
Sponsor: University of California, Los Angeles
Tuberous Sclerosis
United States
Prevalence of Periodontitis in Egyptian Multiple Sclerosis Patients.Completed
NCT07195110N/AUpdated Mar 18, 2026
Sponsor: Cairo University
Multiple Sclerosis (MS) · Periodontal Diseases
Egypt
Effect of Multimodal Exercise Training in Patients With Multiple SclerosisRecruiting
NCT06676618NAUpdated Mar 17, 2026
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisRecruiting
NCT07225361Phase 4Updated Mar 17, 2026
Sponsor: Northwestern University
Multiple Sclerosis · Multiple Sclerosis (MS) - Relapsing-remitting
United States
Effect of Acetominophen an Gait Fatigue in Multiple SclerosisNot Yet Recruiting
NCT07440446N/AUpdated Mar 17, 2026
Sponsor: Hunter College of City University of New York
Multiple Sclerosis
United States
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 AgonistsRecruiting
NCT07207148N/AUpdated Mar 17, 2026
Sponsor: Northwestern University
Multiple Sclerosis
United States
Using Motor Imagery-based Brain-computer Interface With Multiple Sclerosis Patients.Not Yet Recruiting
NCT07472556NAUpdated Mar 16, 2026
Sponsor: Pasquale Arpaia
Multiple Sclerosis
Italy
Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis FatigueRecruiting
NCT06809192NAUpdated Mar 16, 2026
Sponsor: University of Washington
Multiple Sclerosis
United States
Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple SclerosisRecruiting
NCT07174973NAUpdated Mar 16, 2026
Sponsor: University Health Network, Toronto
Multiple Sclerosis · Mobility Limitation · Balance; Distorted · Gait
Canada
Serious Game Rehabilitation and Brain Plasticity in MSNot Yet Recruiting
NCT07474129NAUpdated Mar 16, 2026
Sponsor: Lille Catholic University
Multiple Sclerosis (MS)
Effects of Qigong Therapy in MS PatientsActive Not Recruiting
NCT07473180NAUpdated Mar 16, 2026
Sponsor: Baskent University
Multiple Sclerosis
Turkey (Türkiye)
Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple SclerosisTerminated
NCT02904876Phase 4Updated Mar 16, 2026
Sponsor: University Hospital, Strasbourg, France
Multiple Sclerosis
France
Common and Specific Information From Neuroimaging and SmartphoneRecruiting
NCT05482906N/AUpdated Mar 13, 2026
Sponsor: Nantes University Hospital
Multiple Sclerosis
France
Longitudinal Assessment of Iron Rims in MS LesionsRecruiting
NCT05123443N/AUpdated Mar 12, 2026
Sponsor: Nottingham University Hospitals NHS Trust
Multiple Sclerosis
United Kingdom
Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis PatientsActive Not Recruiting
NCT06854094N/AUpdated Mar 12, 2026
Sponsor: Ente Ospedaliero Cantonale, Bellinzona
Multiple Sclerosis
Switzerland
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisActive Not Recruiting
NCT04749667Phase 1, Phase 2Updated Mar 12, 2026
Sponsor: Haukeland University Hospital
Multiple Sclerosis · Progressive Multiple Sclerosis
Norway
Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)Completed
NCT06634225N/AUpdated Mar 12, 2026
Sponsor: Lille Catholic University
Multiple Sclerosis · Medical Device · Coordination and Balance Disturbances
France

Previous page Next page